|
Request for analytical method support – N-nitroso-piperidine in LVP elastomeric packaging (E&L study)
|
|
0
|
109
|
March 19, 2026
|
|
Available Tools for Prediction of Potential Degradation Products from Nitrosation Reactions
|
|
4
|
262
|
February 4, 2026
|
|
Nitrosamine Impurities: The Analytical & Regulatory Roadmap (2024-2025)
|
|
0
|
384
|
January 20, 2026
|
|
Limit of Common or Small Nitrosamine Impurities in RSM irrespective of any particular MDD
|
|
9
|
316
|
January 21, 2026
|
|
Nitrosamine impurity evaluation in animal health API
|
|
2
|
107
|
January 15, 2026
|
|
Calling our Risk Assessment Experts
|
|
52
|
1708
|
December 30, 2025
|
|
The Impact of API Synthesis Optimization on Reducing Nitrosamine Risk: A Technical Walkthrough
|
|
0
|
245
|
December 20, 2025
|
|
I found a recent review paper on nitrsoamine risk assessment in pharmaceuticals
|
|
6
|
727
|
December 3, 2025
|
|
Nitrosamine Bootcamp in Indonesia & Korea
|
|
0
|
237
|
November 4, 2025
|
|
Monitoring the Concentration of Nitrogen Oxides in the Fluidized Bed Drying/Granulation Process and Evaluation of Reduction Methods
|
|
2
|
498
|
September 28, 2025
|
|
Analytical challenge for determination of instable standard of other N-nitroso structure
|
|
10
|
832
|
September 22, 2025
|
|
Stability in risk assessment report
|
|
12
|
568
|
September 10, 2025
|
|
Nitrosamines risk in cleaning validation approach
|
|
11
|
380
|
September 4, 2025
|
|
Risk Assessment Tool community review -launch
|
|
6
|
931
|
April 8, 2026
|
|
Alignment between Duplex Sequencing and transgenic rodent mutation assay data in the assessment of in vivo NDMA-induced mutagenesis-Pub
|
|
0
|
147
|
July 21, 2025
|
|
CMO Nitrosamine Risk Assessment
|
|
7
|
513
|
June 27, 2025
|
|
How to decide if one anticancer drug is for advanced cancer?
|
|
12
|
743
|
June 13, 2025
|
|
📖 Drug Substance and Drug Product Workflows for Quality Risk Management for the Presence of Nitrosamines in Medicines-Pub
|
|
2
|
1002
|
May 27, 2025
|
|
🇲🇽 Free Lhasa México Symposia: Shaping the Future of Pharma & Regulation 🇲🇽
|
|
0
|
134
|
May 13, 2025
|
|
Total Nitrosamine Analyzer
|
|
3
|
327
|
May 12, 2025
|
|
Health Canada: Nitrosamine impurities Update July 26, 2024
|
|
16
|
1857
|
May 9, 2025
|
|
Nitrosourea, aromatic n-nitroso copmounds
|
|
2
|
260
|
May 2, 2025
|
|
Risk mitigation based on DP specifications
|
|
10
|
702
|
April 7, 2025
|
|
:brazil: Lhasa Brazil Symposium: Aligning Pharma & Regulatory Standards Globally :brazil:
|
|
0
|
160
|
April 3, 2025
|
|
Dr. Andrew Teasdale on the recent updates on Nitrosamine Impurities - Virtual Workshop
|
|
1
|
702
|
March 15, 2025
|
|
NDSRI in finishe products
|
|
2
|
431
|
March 13, 2025
|
|
DBU: 1,8-Diazabicyclo[5.4.0]undec-7-ene
|
|
0
|
170
|
March 6, 2025
|
|
Impact of Antioxidant Excipients on N-nitrosamine Formation and Bioequivalence in Metformin Formulations - Pub
|
|
3
|
763
|
February 11, 2025
|
|
FREE Lhasa Webinar | Nitrosaminas en el horizonte: ¿Está preparado? 🇲🇽
|
|
1
|
306
|
January 22, 2025
|
|
Exploration for Chemical Filter Cartridges that Can Reduce Nitrogen Oxides, a Common Factor in the Formation of Nitrosamines
|
|
0
|
282
|
December 15, 2024
|